I would bet donuts to dollars that Sanofi will NOT have anything to do with Brilacidin. They are already working with BARDA and GSK on a recombinant protein adjuvanted vaccine AND with Translate Bio on an mRNA-based vaccine. Sanofi already has plans to advance the first one into a Ph III if this months data is good.
News 
Market Data 
Discover 
AI
